Umlobi: Virginia Floyd
Usuku Lokudalwa: 10 Agasti 2021
Ukuvuselela Usuku: 1 Ujulayi 2024
Anonim
Yerba Mate | Thirsty For ...
Ividiyo: Yerba Mate | Thirsty For ...

-Delile

I-Yerba mate isitshalo. Amaqabunga asetshenziselwa ukwenza umuthi.

Abanye abantu bathatha i-yerba mate ngomlomo ukuze banciphise ukukhathala ngokwengqondo nangokomzimba (ukukhathala), kanye ne-chronic fatigue syndrome (i-CFS). Iphinde ithathwe ngomlomo ngezikhalazo ezihlobene nenhliziyo kufaka phakathi ukwehluleka kwenhliziyo, ukushaya kwenhliziyo okungajwayelekile, nomfutho wegazi ophansi.

Abanye abantu futhi bathatha i-yerba mate ngomlomo ukuze bathuthukise imizwa nokudangala; yesifo sikashukela; i-cholesterol ephezulu; amathambo abuthakathaka (i-osteoporosis); ukudambisa ikhanda nezinhlungu ezihlangene; ukwelapha izifo ezithwala umchamo (UTIs), namatshe esinye nesezinso; yokwehlisa isisindo; futhi njenge-laxative.

Ekudleni, i-yerba mate isetshenziselwa ukwenza isiphuzo esifana netiye.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze YERBA MATE zimi kanje:


Ubufakazi obanele bokukala ukusebenza kwe ...

  • Ukusebenza kwezemidlalo. Ucwaningo lwakuqala lukhombisa ukuthi umthamo owodwa we-yerba mate ngaphambi kokuzivocavoca unganciphisa indlala ngaphambi kokuzivocavoca futhi uthuthukise imizwa ngemuva kokuzivocavoca kwabesifazane. Olunye ucwaningo lukhombisa ukuthi ukuthatha i-yerba mate nsuku zonke izinsuku ezi-5 kungahle kuthuthukise ukusebenza kokuzivocavoca kubasubathi abaqeqeshiwe.
  • Amakhono wokukhumbula nokucabanga (umsebenzi wokuqonda). Ucwaningo lokuqala lukhombisa ukuthi ukuphuza isiphuzo esiqukethe i-yerba mate akwenzi ngcono inkumbulo, isikhathi sokuphendula, noma ukunemba kwengqondo kwabesifazane abaphilile.
  • Isifo sikashukela. Ucwaningo lokuqala lukhombisa ukuthi ukuphuza itiye le-yerba mate kathathu nsuku zonke izinsuku ezingama-60 kungehlisa ushukela egazini kubantu abanesifo sikashukela sohlobo 2.
  • Izinga eliphakeme le-cholesterol noma amanye amafutha (lipids) egazini (hyperlipidemia). Ucwaningo lwakuqala lukhombisa ukuthi ukuphuza itiye eliqukethe i-yerba mate kathathu nsuku zonke izinsuku ezingama-40 kunganciphisa inani eliphelele le-cholesterol ne-low-density lipoprotein (LDL noma "bad") cholesterol, futhi kukhuphule i-high-density lipoprotein (HDL noma "okuhle") cholesterol, kubantu nge-cholesterol ephezulu. Lokhu kufaka phakathi abantu asebevele bethatha izidakamizwa ze-statin. Kodwa-ke, olunye ucwaningo lwakuqala lukhombisa ukuthi i-yerba mate ayishintshi amazinga e-lipid kubantu abadala abane-HIV abangenayo i-cholesterol ephezulu.
  • Ukukhuluphala ngokweqile. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-yerba mate ngomlomo kunganciphisa amafutha futhi kudale ukwehla kwesisindo lapho kusetshenziswa wedwa noma kuhlanganiswe ne-guarana ne-damiana.
  • Amathambo abuthakathaka futhi anamandla (i-osteoporosis). Ukuphuza itiye mate mate nsuku zonke okungenani iminyaka engu-4 kungahle kunciphise izinga lokulahleka kwamathambo kwabesifazane be-postmenopausal. Kodwa-ke, olunye ucwaningo lukhombisa ukuthi i-yerba mate ingahle ingabi nomthelela ezingeni lokulahleka kwamathambo kwabesifazane be-postmenopausal.
  • Isifo sikashukela. Ucwaningo lokuqala lukhombisa ukuthi ukuphuza itiye le-yerba mate kathathu nsuku zonke izinsuku ezingama-60 akwehlisi ukuzila ushukela wegazi kubantu abane-prediabetes. Kodwa-ke, ingahle inciphise i-hemoglobin (HbA1C) ene-glycated, isilinganiso seshukela egazini elijwayelekile.
  • Isifo sokukhathala okungamahlalakhona (CFS).
  • Ukuqunjelwa.
  • Ukucindezeleka.
  • Ukuphathwa ikhanda.
  • Izimo zenhliziyo.
  • Izinso zezinso nezesinye.
  • Umfutho wegazi ophansi.
  • Ukutheleleka kwe-Urinary tract (UTIs).
  • Ezinye izimo.
Kudingeka ubufakazi obuningi ukukala ukusebenza kwe-yerba mate kulokhu kusetshenziswa.

I-Yerba mate iqukethe i-caffeine namanye amakhemikhali ashukumisa ubuchopho, inhliziyo, imisipha efaka imithambo yegazi, nezinye izitho zomzimba. Lapho ithathwa ngomlomo:Umlingani we-Yerba unjalo OKUNGENZEKA UKUPHEPHA kubantu abaningi lapho kuthathwe isikhathi esifushane. I-Yerba mate iqukethe i-caffeine, okuthi kwabanye abantu ingadala imiphumela emibi efana nokungakwazi ukulala (ukuqwasha), ukwethuka nokungazinzi, isisu esithukuthele, isicanucanu nokuhlanza, ukukhuphuka kwenhliziyo nokuphefumula, neminye imiphumela emibi.

Umlingani we-Yerba unjalo MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngamanani amakhulu noma isikhathi eside. Ukudla inani elikhulu le-yerba mate (ngaphezu kwezinkomishi eziyi-12 nsuku zonke) kungadala ikhanda, ukukhathazeka, ukuyaluza, ukukhala ezindlebeni, nokushaya kwenhliziyo okungajwayelekile. Ukuphuza amanani amaningi e-yerba mate (amalitha angu-1-2 nsuku zonke) futhi kwandisa amathuba okuba nomdlavuza wokuqopha, umdlavuza wezinso, umdlavuza wesisu, umdlavuza wesinye, umdlavuza wesibeletho, umdlavuza wendlala yabesilisa, umdlavuza wamaphaphu, futhi nomdlavuza welaryngeal noma womlomo. Le ngozi iphezulu kakhulu kubantu ababhemayo noma abaphuza utshwala.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Umlingani we-Yerba unjalo MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngomlomo ngesikhathi sokukhulelwa. Okukhathazayo ukuthi ukusebenzisa i-yerba mate kubonakala kukhulisa ubungozi bokuthola umdlavuza. Akwaziwa noma leyo ngozi idluliselwa embungwini osakhulayo. Okunye okukhathazayo okuqukethwe yi-caffeine ye-yerba mate. I-caffeine inqamula i-placenta bese ingena egazini lombungu, ikhiqize amazinga e-caffeine embungwini afana nezinga le-caffeine kunina. Ngokuvamile, omama kufanele bagweme ukusebenzisa ngaphezu kwe-300 mg ye-caffeine nsuku zonke; lokho cishe yizinkomishi eziyi-6 zerba mate. Izinsana ezizalwa omama abadla i-caffeine eningi ngesikhathi sokukhulelwa kwesinye isikhathi zikhombisa izimpawu zokuhoxa kwe-caffeine ngemuva kokuzalwa. Ukweqiwa okuphezulu kwe-caffeine nakho kuye kwaxhunyaniswa nokukhulelwa kwesisu, ukubeletha ngaphambi kwesikhathi, nesisindo sokuzalwa esiphansi. Kodwa-ke, abacwaningi bafunde omama abaphuza itiye le-yerba mate ngesikhathi sokukhulelwa futhi abatholanga ukuxhumana okuqinile phakathi kokuphuza i-yerba mate nokubeletha ngaphambi kwesikhathi noma isisindo esincane sokuzalwa. Kepha lolu cwaningo selugxekiwe ngoba aluzange lubheke inani le-yerba mate noma le-caffeine elisetshenziswa omama; bekubheka kuphela ukuthi basebenzise kangaki i-yerba mate.

Umlingani we-Yerba naye MHLAWUMBI ANGIPHEPHILE ngesikhathi sokuncelisa. Akwaziwa noma amakhemikhali abangela umdlavuza akwi-yerba mate angena yini ebisini lwebele, kepha lokho kuyakhathaza. I-caffeine ese-yerba mate nayo iyinkinga. Kungadala ukucasuka nokwenyuka kokuhamba kwamathumbu ezinganeni ezincelisayo.

Izingane: Umlingani we-Yerba unjalo MHLAWUMBI ANGIPHEPHILE yezingane lapho zithathwa ngomlomo. Umlingani we-Yerba uxhunyaniswe nengozi eyengeziwe yomdlavuza wokuqopha, umdlavuza wezinso, umdlavuza wesisu, umdlavuza wesinye, umdlavuza wesibeletho, umdlavuza wendlala yabesilisa, umdlavuza wamaphaphu, futhi nomdlavuza welaryngeal noma womlomo.

Ukuphuza ngokweqile: Ukusetshenziswa kotshwala obuningi kuhlangene nokusetshenziswa kwe-yerba mate kwesikhathi eside kwandisa ubungozi besifo somdlavuza kusuka kathathu kuya kwesikhombisa.

Izinkinga zokukhathazeka: I-caffeine e-yerba mate ingenza izinkinga zokukhathazeka zibe zimbi kakhulu.

Izinkinga zokopha: I-caffeine inganciphisa ukuvimba. Ngenxa yalokhu, kunokukhathazeka ukuthi i-caffeine ese-yerba mate ingenza ukuphazamiseka kokopha kube kubi kakhulu. Kepha kuze kube manje, lo mphumela awukabikwa kubantu.

Izimo zenhliziyo: I-caffeine ese-yerba mate ingadala ukushaya kwenhliziyo okungajwayelekile kubantu abathile. Uma unesimo senhliziyo, xoxa ngokusebenzisa i-yerba mate nomhlinzeki wakho wezokunakekelwa kwempilo.

Isifo sikashukela: Olunye ucwaningo lukhombisa ukuthi i-caffeine ese-yerba mate ingathinta indlela abantu abanesifo sikashukela abasebenza ngayo ushukela futhi ingahle ibe nzima ukulawula ushukela egazini. Kukhona nolunye ucwaningo oluthokozisayo olukhombisa ukuthi i-caffeine ingenza izimpawu zokuxwayisa ngoshukela ophansi wegazi kubantu abanesifo sikashukela sohlobo 1 zibonakale kakhulu. Olunye ucwaningo lukhombisa ukuthi izimpawu zikashukela wegazi ziphansi kakhulu uma ziqala lapho kungekho i-caffeine, kepha njengoba ushukela ophansi wegazi uqhubeka, izimpawu zikhulu nge-caffeine. Lokhu kungakhuphula ikhono labantu abanesifo sikashukela lokuthola nokwelapha ushukela wegazi ophansi. Kodwa-ke, okubi ukuthi i-caffeine ingase ikhulise inani leziqephu ezinoshukela ophansi. Uma unesifo sikashukela, khuluma nomhlinzeki wakho wezokunakekelwa kwempilo ngaphambi kokusebenzisa i-yerba mate.

Uhudo: Umlingani we-Yerba uqukethe i-caffeine. I-caffeine ese-yerba mate, ikakhulukazi uma ithathwa ngobuningi, ingasibhebhethekisa isifo sohudo.

I-Glaucoma: Ukusebenzisa i-yerba mate kwandisa ingcindezi ngaphakathi kweso ngenxa ye-caffeine eyiqukethe. Ukwanda kwengcindezi kwenzeka ngaphakathi kwemizuzu engama-30 futhi kuhlala okungenani imizuzu engama-90. Uma une-glaucoma, xoxa ngokusebenzisa kwakho i-yerba mate nomhlinzeki wakho wezokunakekelwa kwempilo.

Umfutho wegazi ophezulu: Umlingani we-Yerba uqukethe i-caffeine. Ukuphuza i-caffeine kungakhuphula umfutho wegazi kubantu abane-high blood pressure. Kodwa-ke, lo mphumela ungancipha kubantu abaphuza i-caffeine njalo.

I-irritable bowel syndrome (IBS): Umlingani we-Yerba uqukethe i-caffeine. I-caffeine e-yerba mate, ikakhulukazi uma ithathwa ngobuningi, ingase ibe sibi kakhulu isifo sohudo futhi ingase izibhebhethekise izimpawu ze-IBS.

Amathambo abuthakathaka (i-osteoporosis): Abanye abacwaningi bathole ukuthi abesifazane abaphuma esikhathini sokuya esikhathini abaphuza izinkomishi ezi-4 noma ngaphezulu nsuku zonke zetiye lendabuko laseNingizimu Melika elinamandla amakhulu amathambo. Kepha olunye ucwaningo lukhombisa ukuthi i-yerba mate ingahle ingabi namphumela emathanjeni abesifazane besifazane abasesikhathini. Futhi, i-caffeine ese-yerba mate ivame ukukhipha i-calcium emzimbeni womchamo. Lokhu kungaba nomthelela emathanjeni abuthakathaka. Uma une-osteoporosis, nciphisa ukusetshenziswa kwe-caffeine ibe ngaphansi kuka-300 mg ngosuku (cishe izinkomishi ezi-6 ze-yerba mate). Ukuthatha i-calcium eyengeziwe kungasiza ekwenzeni i-calcium ekhishwe ngaphandle. Uma uvame ukuba nempilo enhle futhi uthola i-calcium eyanele ekudleni kwakho nakwizithasiselo, ukuthatha u-400 mg we-caffeine nsuku zonke (cishe izinkomishi eziyi-8-10 ze-yerba mate) akubonakali kwandisa ubungozi bokuthola i-osteoporosis. Abesifazane be-Postmenopausal abanesimo esizuzwe njengefa esibenza bangaqhubeki nokwenza uvithamini D ngokujwayelekile, kufanele baqaphele ikakhulukazi lapho besebenzisa i-caffeine.

Kukhona abanye besifazane abasengozini ekhethekile yamathambo abuthakathaka. Laba besifazane banesimo esizuzwe njengefa esenza kube nzima ukuthi basebenzise kahle uvithamini D. UVitamin D usebenza nge calcium ukwakha amathambo aqinile. Laba besifazane kufanele baqaphele ikakhulukazi ukukhawulela inani le-caffeine abayithola ku-yerba mate nakweminye imithombo.

Ukubhema: Ingozi yokuthola umdlavuza iphindwe kathathu kuye kwezi-7 kubantu ababhemayo futhi abasebenzisa i-yerba mate isikhathi eside.

Okukhulu
Ungathathi le nhlanganisela.
Ama-Amphetamines
Izidakamizwa ezikhuthazayo ezifana nama-amphetamine zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi ikhuphule izinga lokushaya kwenhliziyo yakho. I-caffeine ese-yerba mate nayo ingasheshisa uhlelo lwezinzwa. Ukuthatha i-yerba mate kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kubandakanya ukukhuphuka kwenhliziyo nomfutho wegazi ophezulu. Gwema ukuthatha izidakamizwa ezivuselelayo kanye ne-yerba mate.
Cocaine
Izidakamizwa ezikhuthazayo ezifana ne-cocaine zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi ikhuphule izinga lokushaya kwenhliziyo yakho. I-caffeine ese-yerba mate nayo ingasheshisa uhlelo lwezinzwa. Ukuthatha i-yerba mate kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kubandakanya ukukhuphuka kwenhliziyo nomfutho wegazi ophezulu. Gwema ukuthatha izidakamizwa ezivuselelayo kanye ne-yerba mate.
Ephedrine
Izidakamizwa ezikhuthazayo zisheshisa isimiso sezinzwa. I-caffeine (equkethwe ku-yerba mate) ne-ephedrine yizidakamizwa ezivuselelayo. Ukuthatha i-caffeine kanye ne-ephedrine kungadala ukukhuthazeka kakhulu futhi kwesinye isikhathi kube nemiphumela emibi kakhulu nezinkinga zenhliziyo. Ungathathi imikhiqizo equkethe i-caffeine kanye ne-ephedrine ngasikhathi sinye.
Maphakathi
Qaphela ngale nhlanganisela.
I-Adenosine (Adenocard)
I-Yerba mate iqukethe i-caffeine. I-caffeine ese-yerba mate ingavimba imiphumela ye-adenosine (Adenocard). I-Adenosine (i-Adenocard) ivame ukusetshenziswa odokotela ukwenza ukuhlolwa enhliziyweni. Lokhu kuhlolwa kubizwa ngokuthi yi-cardiac test test. Misa ukusebenzisa umlingani we-yerba noma eminye imikhiqizo equkethe i-caffeine okungenani amahora angama-24 ngaphambi kokuhlolwa kwengcindezi yenhliziyo.
Ama-antibiotic (ama-antibiotic e-Quinolone)
I-Yerba mate iqukethe i-caffeine. Umzimba wephula i-caffeine ese-yerba mate ukuze uyiqede. Amanye ama-antibiotic anganciphisa ukuthi umzimba uphula ngokushesha kanjani i-caffeine. Ukuthatha le mithi kanye ne-caffeine kungakhuphula ubungozi bemiphumela emibi kubandakanya i-jitteriness, ikhanda, ukukhuphuka kwenhliziyo, nokunye.

Amanye ama-antibiotic anciphisa ukuthi umzimba weqa kanjani i-caffeine ngokushesha afaka i-ciprofloxacin (Cipro), i-gemifloxacin (i-Factive), i-levofloxacin (i-Levaquin), i-moxifloxacin (i-Avelox), i-ofloxacin (i-Floxin), neminye.
I-Carbamazepine (Tegretol)
ICarbamazepine isidakamizwa esisetshenziselwa ukwelapha ukuquleka. I-caffeine inganciphisa imiphumela ye-carbamazepine. Njengoba i-yerba mate iqukethe i-caffeine, ngokombono ukuthatha i-yerba mate ne-carbamazepine kunganciphisa imiphumela ye-carbamazepine futhi kwandise ubungozi bokuquleka kwabanye abantu.
I-Cimetidine (Tagamet)
I-Yerba mate iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Cimetidine (Tagamet) inganciphisa ukuthi umzimba wakho wephula ngokushesha kanjani i-caffeine. Ukuthatha i-cimetidine (Tagamet) kanye ne-yerba mate kungakhuphula amathuba okuba nemiphumela emibi ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu, ukushaya kwenhliziyo okusheshayo, nokunye.
I-Clozapine (Clozaril)
Umzimba wephula i-clozapine (i-Clozaril) ukuze uyiqede. I-caffeine ese-yerba mate ibonakala incipha ukuthi umzimba wephula kanjani i-clozapine (Clozaril) ngokushesha. Ukuthatha i-yerba mate kanye ne-clozapine (i-Clozaril) kungakhuphula imiphumela kanye nemiphumela emibi ye-clozapine (Clozaril).
I-Dipyridamole (Persantine)
I-Yerba mate iqukethe i-caffeine. I-caffeine ese-yerba mate ingavimba imiphumela ye-dipyridamole (Persantine). IDipyridamole (Persantine) ivame ukusetshenziswa odokotela ukwenza ukuhlolwa enhliziyweni. Lokhu kuhlolwa kubizwa ngokuthi yi-cardiac test test. Misa ukusebenzisa i-yerba mate noma eminye imikhiqizo equkethe i-caffeine okungenani amahora angama-24 ngaphambi kokuhlolwa kwengcindezi yenhliziyo.
I-Disulfiram (Antabuse)
Umzimba wephula i-caffeine ukuze uyiqede. I-Disulfiram (Antabuse) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha okukhulu. Ukuthatha i-yerba mate (equkethe i-caffeine) kanye ne-disulfiram (i-Antabuse) kungakhuphula imiphumela kanye nemiphumela emibi ye-caffeine kufaka phakathi i-jitteriness, hyperactivity, irritability, nabanye.
Ama-Estrogens
Umzimba wephula i-caffeine (equkethwe ku-yerba mate) ukuze uyiqede. Ama-Estrogens anganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukunciphisa ukuwohloka kwe-caffeine kungadala ukuqina, ikhanda, ukushaya kwenhliziyo okusheshayo, neminye imiphumela emibi. Uma uthatha ama-estrogens, nciphisa umthamo wakho we-caffeine.

Amanye amaphilisi e-estrogen afaka phakathi ama-equine estrogens ahlanganisiwe (Premarin), i-ethinyl estradiol, i-estradiol namanye.
I-Ethosuximide (Zarontin)
I-Ethosuximide yisidakamizwa esisetshenziselwa ukwelapha ukuquleka. I-caffeine ese-yerba mate inganciphisa imiphumela ye-ethosuximide. Ukuthatha i-yerba mate nge-ethosuximide kunganciphisa imiphumela ye-ethosuximide futhi kwandise ubungozi bokuquleka kwabanye abantu.
I-Felbamate (Felbatol)
I-Felbamate yisidakamizwa esisetshenziselwa ukwelapha ukuquleka. I-caffeine e-yerba mate inganciphisa imiphumela ye-felbamate. Ukuthatha i-yerba mate nge-felbamate kunganciphisa imiphumela ye-felbamate futhi kukhuphule ubungozi bokuquleka kwabanye abantu.
I-Flutamide (Eulexin)
Umzimba wephula i-flutamide (i-Eulexin) ukuze uyiqede. I-caffeine ese-yerba mate inganciphisa ukuthi umzimba ususa kanjani i-flutamide ngokushesha okukhulu. Lokhu kungadala ukuthi i-flutamide ihlale emzimbeni isikhathi eside futhi inyuse ubungozi bemiphumela emibi.
I-Fluvoxamine (Luvox)
Umzimba wephula i-caffeine ese-yerba mate ukuze uyiqede. I-Fluvoxamine (Luvox) inganciphisa ukuthi umzimba uyiphula masinyane kanjani i-caffeine. Ukuthatha i-yerba mate kanye ne-fluvoxamine (i-Luvox) kungadala i-caffeine eningi kakhulu emzimbeni, futhi kukhulise imiphumela kanye nemiphumela emibi ye-yerba mate.
ILithium
Umzimba wakho ngokwemvelo ususa i-lithium. I-caffeine ese-yerba mate ingakhuphula ukuthi umzimba wakho ususa i-lithium ngokushesha kangakanani. Uma uthatha imikhiqizo equkethe i-caffeine futhi uphuza i-lithium, yeka ukuthatha imikhiqizo ye-caffeine kancane. Ukumisa i-yerba mate ngokushesha okukhulu kungakhuphula imiphumela emibi ye-lithium.
Imithi ye-asthma (i-Beta-adrenergic agonists)
I-Yerba mate iqukethe i-caffeine. I-caffeine ingashukumisa inhliziyo. Eminye imishanguzo ye-asthma nayo ingashukumisa inhliziyo. Ukuthatha i-caffeine ngemithi ethile ye-asthma kungadala ukukhuthazeka kakhulu futhi kubangele izinkinga zenhliziyo.

Eminye imishanguzo yesifuba somoya ihlanganisa i-albuterol (Proventil, Ventolin, Volmax), metaproterenol (Alupent), terbutaline (Bricanyl, Brethine), isoproterenol (Isuprel), neminye.
Imithi yokudangala (MAOIs)
I-caffeine ese-yerba mate ingakhuthaza umzimba. Eminye imishanguzo esetshenziselwa ukucindezeleka nayo ingakhuthaza umzimba. Ukuphuza i-yerba mate nokuthatha imishanguzo ethile yokudangala kungahle kukhuthaze umzimba kakhulu futhi kube nemiphumela emibi kakhulu efaka ukushaya kwenhliziyo okusheshayo, umfutho wegazi ophakeme, uvalo nokunye.

Eminye yale mithi esetshenziselwa ukucindezeleka ifaka i-rasagiline (Azilect), i-selegiline (i-Eldepryl, i-Zelapar), i-tranylcypromine (i-Parnate), i-phenelzine (i-Nardil), neminye.
Imithi eyehlisa ukunqamuka kwegazi (Anticoagulant / Antiplatelet drug)
I-Yerba mate iqukethe i-caffeine. I-caffeine inganciphisa ukuvimba kwegazi. Ukuthatha umlingani we-yerba kanye nemithi nayo ejija kancane ingakhuphula amathuba okulimala nokopha.

Eminye imishanguzo eyehlisa ijubane ukuvala igazi ifaka phakathi i-aspirin, i-clopidogrel (i-Plavix), i-diclofenac (i-Voltaren, i-Cataflam, abanye), i-ibuprofen (i-Advil, i-Motrin, abanye), i-naproxen (i-Anaprox, i-Naprosyn, abanye), i-dalteparin (i-Fragmin), i-enoxaparin (i-Lovenox) , heparin, warfarin (Coumadin), nabanye.
I-Nicotine
Izidakamizwa ezikhuthazayo ezifana ne-nicotine zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi ikhuphule izinga lokushaya kwenhliziyo yakho. I-caffeine ese-yerba mate nayo ingasheshisa uhlelo lwezinzwa. Ukuthatha i-yerba mate kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kubandakanya ukukhuphuka kwenhliziyo nomfutho wegazi ophezulu. Gwema ukuthatha izidakamizwa ezivuselelayo kanye ne-yerba mate.
I-Pentobarbital (Nembutal)
Imiphumela evuselelayo ye-caffeine ku-yerba mate ingavimba imiphumela ekhiqiza ukulala ye-pentobarbital.
I-Phenobarbital (Luminal)
I-Phenobarbital yisidakamizwa esisetshenziselwa ukwelapha ukuquleka. I-caffeine ese-yerba mate inganciphisa imiphumela ye-phenobarbital futhi inyuse ubungozi bokuquleka kwabanye abantu.
I-Phenylpropanolamine
I-Yerba mate iqukethe i-caffeine. I-caffeine ingakhuthaza umzimba. I-Phenylpropanolamine nayo ingashukumisa umzimba. Ukuthatha i-yerba mate ne-phenylpropanolamine ndawonye kungahle kukhuthaze kakhulu futhi kwandise ukushaya kwenhliziyo nomfutho wegazi futhi kubangele ukwethuka.
I-Phenytoin (Dilantin)
I-Phenytoin yisidakamizwa esisetshenziselwa ukwelapha ukuquleka. I-caffeine ese-yerba mate inganciphisa imiphumela ye-phenytoin. Ukuthatha umlingani we-yerba nge-phenytoin kungahle kunciphise imiphumela ye-phenytoin futhi kwandise ubungozi bokuquleka kwabanye abantu.
Isi-Riluzole (Rilutek)
Umzimba wephula i-riluzole (Rilutek) ukuze uyiqede. Ukuthatha i-yerba mate kunganciphisa ukuthi umzimba wephula kanjani i-riluzole (i-Rilutek) ngokushesha futhi kukhulise imiphumela kanye nemiphumela emibi ye-riluzole.
Imithi yokwelapha (i-Benzodiazepines)
I-Benzodiazepines yizidakamizwa ezibangela ukulala nokozela. Umzimba wephula ama-benzodiazepines ukuwaqeda. I-caffeine ese-yerba mate inganciphisa ukonakala kwe-benzodiazepines. Lokhu kungakhuphula imiphumela ye-benzodiazepines futhi kubangele ukulala kakhulu. Ungasebenzisi i-yerba mate uma uthatha ama-benzodiazepines.

Amanye ama-benzodiazepines afaka i-alprazolam (Xanax), i-clonazepam (iKlonopin), i-diazepam (i-Valium), i-lorazepam (i-Ativan), nezinye.
Izidakamizwa ezikhuthazayo
Izidakamizwa ezikhuthazayo zisheshisa isimiso sezinzwa. Ngokusheshisa uhlelo lwezinzwa, imithi evuselelayo ingakwenza uzizwe ujittery futhi isheshise ukushaya kwenhliziyo yakho. I-caffeine ese-yerba mate nayo ingasheshisa uhlelo lwezinzwa. Ukudla i-yerba mate kanye nezidakamizwa ezikhuthazayo kungadala izinkinga ezinkulu kufaka phakathi ukukhuphuka kwenhliziyo nomfutho wegazi ophakeme. Gwema ukuthatha izidakamizwa ezivuselelayo kanye ne-yerba mate.

Eminye imishanguzo evuselelayo ifaka phakathi i-diethylpropion (Tenuate), i-epinephrine, i-nicotine, i-cocaine, i-amphetamines, i-phentermine (Ionamin), i-pseudoephedrine (i-Sudafed), neminye eminingi.
Theophylline
I-Yerba mate iqukethe i-caffeine. I-caffeine isebenza ngokufanayo ne-theophylline. I-caffeine nayo inganciphisa ukuthi umzimba ususa kanjani i-theophylline ngokushesha okukhulu. Ukuthatha i-yerba mate kanye ne-theophylline kungakhuphula imiphumela kanye nemiphumela emibi ye-theophylline.
I-Valproate
IValproate yisidakamizwa esisetshenziselwa ukwelapha ukuquleka. I-caffeine e-yerba mate inganciphisa imiphumela ye-valproate futhi inyuse ubungozi bokuquleka kwabanye abantu.
I-Verapamil (Calan, abanye)
Umzimba wephula i-caffeine ese-yerba mate ukuze uyiqede. IVerapamil (Calan, others) inganciphisa ukuthi umzimba ususa kanjani ngokushesha i-caffeine. Ukuphuza i-yerba mate nokuthatha i-verapamil (i-Calan, abanye) kungakhuphula ubungozi bemiphumela emibi ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu, nokushaya kwenhliziyo okwandisiwe.
Amaphilisi wamanzi (Imithi yokwelapha)
I-caffeine inganciphisa amazinga e-potassium. Amaphilisi amanzi nawo anganciphisa amazinga e-potassium. Ukuthatha i-yerba mate kanye namaphilisi amanzi kungakhuphula ingozi yokwehlisa i-potassium kakhulu.

Amanye "amaphilisi amanzi" angaqeda i-potassium afaka i-chlorothiazide (Diuril), chlorthalidone (Thalitone), furosemide (Lasix), hydrochlorothiazide (HCTZ, HydroDiuril, Microzide), namanye.
Okuncane
Qaphela ngale nhlanganisela.
Utshwala (i-Ethanol)
Umzimba wephula i-caffeine ese-yerba mate ukuze uyiqede. Utshwala bunganciphisa ukuthi umzimba wephula ngokushesha kangakanani i-caffeine. Ukuthatha i-yerba mate kanye notshwala kungahle kudale i-caffeine eningi egazini nasemiphumela emibi ye-caffeine kufaka phakathi i-jitteriness, ikhanda elibuhlungu nokushaya kwenhliziyo okusheshayo.
Amaphilisi okulawula inzalo (Izidakamizwa zokuvimbela inzalo)
Umzimba wephula i-caffeine ese-yerba mate ukuze uyiqede. Amaphilisi okulawula ukubeletha anganciphisa ukuthi umzimba wephula kanjani i-caffeine ngokushesha. Ukuthatha i-yerba mate kanye namaphilisi okulawula ukubeletha kungadala ukuqina, ikhanda, ukushaya kwenhliziyo okusheshayo, neminye imiphumela emibi.

Amanye amaphilisi okulawula ukubeletha afaka i-ethinyl estradiol ne-levonorgestrel (Triphasil), i-ethinyl estradiol ne-norethindrone (i-Ortho-Novum 1/35, i-Ortho-Novum 7/7/7), namanye.
I-Fluconazole (Diflucan)
I-Yerba mate iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Fluconazole (i-Diflucan) ingahle yehlise ukuthi umzimba ususa i-caffeine ngokushesha kangakanani. Lokhu kungadala ukuthi i-caffeine ihlale isikhathi eside emzimbeni futhi inyuse ubungozi bemiphumela emibi efana novalo, ukukhathazeka nokuqwasha.
Imithi yesifo sikashukela (Imithi elwa nesifo sikashukela)
Imithi yesifo sikashukela isetshenziselwa ukwehlisa ushukela wegazi. I-Yerba mate iqukethe i-caffeine. Imibiko ithi i-caffeine ingakhuphula noma inciphise ushukela egazini. I-Yerba mate ingaphazamisa ukulawulwa kukashukela egazini futhi yehlise ukusebenza kwemithi yesifo sikashukela. Bheka ushukela wegazi lakho eduze. Umthamo wemithi yakho yesifo sikashukela ungadinga ukuguqulwa.

Eminye imithi esetshenziselwa isifo sikashukela ifaka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .
Imithi eyehlisa ukwehla kweminye imithi ngesibindi (i-Cytochrome P450 CYP1A2 (CYP1A2) inhibitors)
I-Yerba mate iqukethe i-caffeine. I-caffeine idilizwa yisibindi. Eminye imishanguzo inciphisa indlela isibindi esiyichitha ngayo eminye imithi. Le mithi eshintsha isibindi inganciphisa ukuthi i-caffeine esheshayo kumlingani we-yerba yehle kanjani emzimbeni. Lokhu kungakhuphula imiphumela kanye nemiphumela emibi ye-caffeine ku-yerba mate. Eminye imishanguzo eshintsha isibindi ifaka i-cimetidine (Tagamet), i-fluvoxamine, i-mexiletine, i-clozapine, i-theophylline, neminye.
I-Metformin (iGlucophage)
I-Yerba mate iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Metformin (i-Glucophage) inganciphisa ukuthi umzimba wehla ngokushesha kanjani i-caffeine. Ukuthatha i-yerba mate kanye ne-metformin kungahle kudale i-caffeine eningi emzimbeni, futhi kwandise imiphumela kanye nemiphumela emibi ye-caffeine.
I-Methoxsalen (Oxsoralen)
I-Yerba mate iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Methoxsalen (i-Oxsoralen) inganciphisa ukuthi umzimba wephula ngokushesha kanjani i-caffeine. Ukuthatha i-caffeine kanye ne-methoxsalen kungadala i-caffeine eningi emzimbeni, futhi kwandise imiphumela kanye nemiphumela emibi ye-caffeine.
I-Mexiletine (Mexitil)
I-Yerba mate iqukethe i-caffeine. Umzimba wephula i-caffeine ukuze uyiqede. I-Mexiletine (Mexitil) inganciphisa ukuthi umzimba wephula ngokushesha kanjani i-caffeine. Ukuthatha iMexiletine (Mexitil) kanye ne-yerba mate kungakhuphula imiphumela ye-caffeine kanye nemiphumela emibi ye-yerba mate.
I-Terbinafine (Lamisil)
Umzimba wephula i-caffeine (equkethwe ku-yerba mate) ukuze uyiqede. I-Terbinafine (i-Lamisil) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha futhi inyuse ubungozi bemiphumela emibi kubandakanya i-jitteriness, ikhanda elibuhlungu, ukushaya kwenhliziyo okwengeziwe, neminye imiphumela.
I-Tiagabine (Gabitril)
I-Yerba mate iqukethe i-caffeine. Ukuthatha i-caffeine isikhathi esithile kanye ne-tiagabine kungakhuphula inani le-tiagabine emzimbeni. Lokhu kungakhuphula imiphumela kanye nemiphumela emibi ye-tiagabine.
I-Ticlopidine (Ticlid)
Umzimba wephula i-caffeine ese-yerba mate ukuze uyiqede. I-Ticlopidine (Ticlid) inganciphisa ukuthi umzimba ususa kanjani i-caffeine ngokushesha okukhulu. Ukuthatha i-yerba mate kanye ne-ticlopidine kungakhuphula imiphumela kanye nemiphumela emibi ye-caffeine, kufaka phakathi i-jitteriness, hyperactivity, irritability, nabanye
Okumunyu okusawolintshi
Ungasebenzisi i-yerba mate nge-orange ebabayo. Inhlanganisela ingahle yeqise umzimba, kuholele ekukhuphukeni kwengcindezi yegazi nokushaya kwenhliziyo, ngisho nakubantu abanomfutho wegazi ojwayelekile.
Amakhambi aqukethe i-caffeine nezithako
I-Yerba mate iqukethe i-caffeine. Ukuyisebenzisa kanye namanye amakhambi noma izithasiselo eziqukethe i-caffeine kungakhuphula ubungozi bemiphumela emibi ehlobene ne-caffeine. Eminye imikhiqizo yemvelo equkethe i-caffeine ifaka i-cocoa, ikhofi, i-cola nut, itiye elimnyama, itiye le-oolong ne-guarana.
I-calcium
I-caffeine ese-yerba mate ivame ukwandisa ukuqedwa komzimba kwe-calcium. Uma usebenzisa i-yerba mate eningi, cela umhlinzeki wakho wezokunakekelwa kwezempilo ukuthi kufanele uthathe i-calcium eyengeziwe ukusiza ukwenza i-calcium elahlekile emchameni.
I-Creatine
Kukhona okunye ukukhathazeka ukuthi ukuhlanganisa i-caffeine, ikhemikhali elitholakala ku-yerba mate, ne-ephedra ne-creatine kungakhuphula ubungozi bemiphumela emibi yezempilo. Omunye umsubathi othathe u-6 gram we-creatine monohydrate, 400-600 mg we-caffeine, 40-60 mg we-ephedra, kanye nezinye izithasiselo ezinhlobonhlobo nsuku zonke amaviki ayisi-6 abe nesifo sohlangothi. I-caffeine nayo inganciphisa amandla we-creatine wokuthuthukisa ukusebenza kwezemidlalo.
I-Ephedra (Ma huang)
Ungasebenzisi i-yerba mate nge-ephedra. Le nhlanganisela ingagudluza umzimba futhi inyuse ubungozi bezimo ezisongela impilo noma zokukhubazeka, njengokuphakama komfutho wegazi, isifo senhliziyo, isifo sohlangothi nokuquleka. Le nhlanganisela nayo ingadala ukufa.
Amakhambi nezengezo ezinciphisa ukujiya kwegazi
Umlingani we-Yerba angahle anciphise ukuvimba kwegazi. Ukuyisebenzisa kanye namanye amakhambi noma izithasiselo ezinomphumela ofanayo kungandisa ingozi yokulinyazwa nokopha kwabanye abantu. Amanye ala makhambi afaka i-angelica, i-clove, i-danshen, i-garlic, i-ginger, i-ginkgo, i-Panax ginseng, namanye.
Magnesium
I-Yerba mate iqukethe i-caffeine. I-caffeine ese-yerba mate ingakhuphula ukuthi ingakanani i-magnesium ekhishwa emchameni.
Akukho ukuxhumana okwaziwayo nokudla.
Umthamo ofanele womlingani uncike ezicini eziningana ezifana nobudala bomsebenzisi, impilo, nezinye izimo eziningana. Ngalesi sikhathi alukho ulwazi olwanele lwesayensi ukunquma uhla olufanele lwemithamo yomlingani. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa.

Chimarrao, Green Mate, Hervea, Ilex, Ilex paraguariensis, Tea yaseJesuit yaseBrazil, Tea yamaJesuit, Maté, Maté Folium, Paraguay Tea, Tea yaseSt. , Yerba Mate, Yerba Maté.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. UGómez-Juaristi M, uMartínez-López S, uSarria B, uBravo L, uMateos R.Ukumunca nokwakheka komzimba kwama-yerba mate phenolic compounds kubantu. Ukudla Chem. 2018; 240: 1028-1038. Buka okungaqondakali.
  2. UChaves G, uBritez N, u-Oviedo G, et al. Abaphuza kakhulu iziphuzo ze-Ilex paraguariensis bakhombisa amaphrofayili aphansi we-lipid kepha isisindo somzimba esiphezulu. I-Phytother Res. 2018; 32: 1030-1038. Buka okungaqondakali.
  3. U-Wikoff D, i-Welsh BT, uHenderson R, et al. Ukubuyekezwa okuhlelekile kwemiphumela emibi engaba khona yokusetshenziswa kwe-caffeine kubantu abadala abanempilo, abesifazane abakhulelwe, intsha kanye nezingane. Ukudla Chem Toxicol 2017; 109: 585-648. Buka okungaqondakali.
  4. IVoskoboinik A, uKalman JM, uKistler PM. I-caffeine ne-arrhythmias: isikhathi sokugaya idatha. I-JACC: I-Clin Electrophysiol. I-2018; 4: 425-32.
  5. ULagier D, uNee L, uGuieu R, et al. I-Peri-operative oral caffeine ayivimbeli i-postoperative atrial fibrillation ngemuva kokuhlinzwa kwenhliziyo nge-cardiopulmonary bypass: isilingo somtholampilo esilawulwa ngokungahleliwe. U-Eur J Anaesthesiol. 2018 Ephreli 26. [I-Epub ngaphambi kokuphrinta] Buka okungaqondakali.
  6. USouza SJ, uPetrilli AA, uTeixeira AM, et al. Umphumela weti chocolate kanye netiye kumlingani we-lipid wabantu abane-HIV / AIDS ekwelashweni ngezidambisigciwane: isilingo somtholampilo. Ukudla okunomsoco. 2017 uNov-Dec; 43-44: 61-68. Buka okungaqondakali.
  7. I-Areta JL, i-Austarheim I, iWangensteen H, uCapelli C. Imiphumela ye-Metabolic nokusebenza kwe-yerba mate kubagibeli bamabhayisikili abaqeqeshwe kahle. Ukuzivocavoca kweMed Sci Sports. 2017 Nov 7. Buka okungaqondakali.
  8. UJung JH, uHur YI. Umphumela wokukhishwa komlingani esisindweni somzimba nokwehliswa kwamafutha kwabesifazane abakhuluphele: isilingo somtholampilo esilawulwa ngokungahleliwe. AmaKorea J OBes. 2016; 25: 197-206.
  9. I-Alkhatib A, i-Atcheson R. Yerba Mate (Ilex paraguariensis) ye-metabolic, satiety, kanye nemiphumela yesimo semizwa ekuphumuleni nangesikhathi sokuvivinya umzimba isikhathi eside. Izakhamzimba. 2017 Aug 15; 9. I-Pii: E882. Buka okungaqondakali.
  10. I-da veiga DTA, i-Bringhenti R, iBolignon AA, et al. Ukudla kwe-yerba mate kunethonya elingathathi hlangothi ethanjeni: isifundo sokulawulwa kwamacala kwabesifazane be-postmenopausal. I-Phytother Res. 2018 uJan; 32: 58-64. Buka okungaqondakali.
  11. UZuchinali P, Riberio PA, Pimentel M, da Rosa PR, Zimerman LI, Rohde LE. Umphumela we-caffeine ku-ventricular arrhythmia: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kwezifundo zokuhlola nezomtholampilo. I-Europace 2016 Feb; 18: 257-66. Buka okungaqondakali.
  12. I-International Agency for Research on Cancer (IARC). Ama-monographs e-IARC ahlola ikhofi yokuphuza, umlingani, neziphuzo ezishisa kakhulu. https://www.iarc.fr/en/media-centre/pr/2016/pdfs/pr244_E.pdf. Kufinyelelwe ngoNovemba 1, 2017.
  13. UKim SY, u-Oh MR, uKim MG, uChae HJ, uChae SW. Imiphumela yokulwa nokukhuluphala ngokweqile kwe-yerba mate (Ilex Paraguariensis): isilingo somtholampilo esilawulwa ngokungahleliwe, esingaboni kahle, esilawulwa yi-placebo. I-BMC Complement Altern Med. 2015; 15: 338. Buka okungaqondakali.
  14. Yu S, Yue SW, Liu Z, Zhang T, Xiang N, Fu H. Yerba mate (Ilex paraguariensis) ithuthukisa ama-microcirculation amavolontiya ane-viscosity ephezulu yegazi: isilingo esilawulwa ngokungahleliwe, esingaboni kabili, esilawulwa yi-placebo. Exp Gerontol. 2015; 62: 14-22. Buka okungaqondakali.
  15. UStefani ED, Moore M, uAune D, uDeneo-Pellegrini H, uRonco AL, uBoffetta P, et al. Ukusetshenziswa kweMat kanye nobungozi bomdlavuza: isifundo samacala amaningi sokulawulwa kwamacala e-Uruguay. I-Asian Pac J Cancer Yangaphambilini. 2011; 12: 1089-93. Buka okungaqondakali.
  16. UGambero A noRibeiro ML. Imiphumela emihle ye-yerba mate (Ilex paraguariensis) ekukhuluphaleni. Izakhamzimba. 2015; 7: 730-50. Buka okungaqondakali.
  17. UDixit S, uStein PK, uDewland TA, amaDukes JW, uVittinghoff E, uHeckbert SR, uMarcus GM. Ukusetshenziswa Kwemikhiqizo Ene-caffeine ne-Cardiac Ectopy. J Am Inhliziyo Assoc. 2016 26; 5. pii: e002503. i-doi: 10.1161 / JAHA.115.002503. Buka okungaqondakali.
  18. I-Cheng M, i-Hu Z, i-Lu X, i-Huang J, i-Gu D. Ukudla kwe-Caffeine kanye ne-atrial fibrillation izehlakalo: ukuhlaziywa kwe-meta-analysis analysis of the future cohort studies. Can J Cardiol. 2014 Ephreli; 30: 448-54. i-doi: 10.1016 / j.cjca.2013.12.026. I-Epub 2014 2. Ukubuyekeza. Buka okungaqondakali.
  19. UCaldeira D, uMartins C, u-Alves LB, uPereira H, uFerreira JJ, uCosta J. Caffeine akhuphuli ubungozi be-atrial fibrillation: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta kwezifundo zokubuka. Inhliziyo. 2013; 99: 1383-9. i-doi: 10.1136 / heartjnl-2013-303950. Buyekeza. Buka okungaqondakali.
  20. UMeyer, K. noBall, P. Imiphumela Yezengqondo Nezenhliziyo yeGuarana neYerba Mate: Ukuqhathaniswa neCofi. I-Revista Interamericana de Psicologia 2004; 38: 87-94.
  21. UKlein, GA, Stefanuto, A., Boaventura, BC, de Morais, EC, Cavalcante, Lda S., de, Andrade F., Wazlawik, E., Di Pietro, PF, Maraschin, M., no da Silva, EL. Itiye le-Mate (Ilex paraguariensis) lithuthukisa amaphrofayili we-glycemic kanye ne-lipid ohlobo lwe-2 sikashukela kanye nabantu abangaphambi kwesifo sikashukela: isifundo somshayeli. UJ Am Coll. Umsoco. 2011; 30: 320-332. Buka okungaqondakali.
  22. UHussein, G. M., Matsuda, H., Nakamura, S., Akiyama, T., Tamura, K., no-Yoshikawa, M. Imiphumela yokuvikela neyokuzijabulisa yomlingani (Ilex paraguariensis) kwisifo se-metabolic ku-TSOD amagundane. I-Phytomedicine. 12-15-2011; 19: 88-97. Buka okungaqondakali.
  23. de Morais, EC, Stefanuto, A., Klein, GA, Boaventura, BC, de, Andrade F., Wazlawik, E., Di Pietro, PF, Maraschin, M., no da Silva, EL Ukusetshenziswa kwe-yerba mate (Ilex paraguariensis) ithuthukisa imingcele ye-serum lipid ezifundweni ze-dyslipidemic enempilo futhi inikeze ukwehliswa okungeziwe kwe-LDL-cholesterol kubantu abakwelashwa kwe-statin. J Agric. Ukudla Chem. 9-23-2009; 57: 8316-8324. Buka okungaqondakali.
  24. UMartins, F., Noso, TM, Porto, VB, Curiel, A., Gambero, A., Bastos, DH, Ribeiro, ML, noCarvalho, Pde O. Mate tea inhibits in vitro pancreatic lipase activity and has hypolipidemic effect amagundane akhuluphele kakhulu anokudla okunamafutha amaningi. Ukukhuluphala. (Isilivere.Spring) 2010; 18: 42-47. Buka okungaqondakali.
  25. Arcari, DP, Bartchewsky, W., dos Santos, TW, Oliveira, KA, Funck, A., Pedrazzoli, J., de Souza, MF, Saad, MJ, Bastos, DH, Gambero, A., Carvalho, Pde O ., kanye noRibeiro, ML Imiphumela yokulwa nobunzima kwe-yerba mate extract (Ilex paraguariensis) kumagundane akhuluphele kakhulu anokudla okunamafutha. Ukukhuluphala. (Isilivere.Spring) 2009; 17: 2127-2133. Buka okungaqondakali.
  26. USugimoto, S., Nakamura, S., Yamamoto, S., Yamashita, C., Oda, Y., Matsuda, H., noYoshikawa, M. Imithi yemvelo yaseBrazil. III. izakhiwo ze-triterpene oligoglycosides ne-lipase inhibitors ezivela kumlingani, amaqabunga e-ilex paraguariensis. I-Chem.Pharm.Bull. (Tokyo) 2009; 57: 257-261. Buka okungaqondakali.
  27. Matsumoto, RL, Bastos, DH, Mendonca, S., Nunes, VS, Bartchewsky, W., Ribeiro, ML, no-Oliveira, uCarvalho P. Imiphumela yetiye yomlingani (Ilex paraguariensis) ukungeniswa kwe-mRNA expression of antioxidant enzyme, lipid i-peroxidation, kanye nenani eliphelele le-antioxidant kwabesifazane abasebasha abanempilo. J Agric. Ukudla Chem. 3-11-2009; 57: 1775-1780. Buka okungaqondakali.
  28. I-Pang, J., Choi, Y., nePark, T. Ilex paraguariensis ekhipha ikhuthaza ukukhuluphala okubangelwa ukudla okunamafutha aphezulu: indima engaba khona ye-AMPK kuzicubu ze-visceral adipose. I-Arch.I-Biochemys.I-Biophys. 8-15-2008; 476: 178-185. Buka okungaqondakali.
  29. Miranda, DD, Arcari, DP, Pedrazzoli, J., Jr., Carvalho, Pde O., Cerutti, SM, Bastos, DH, noRibeiro, ML Imiphumela yokuvikela itiye lomlingani (Ilex paraguariensis) ku-H2O2-eyenziwe ngomonakalo we-DNA Ukulungiswa kwe-DNA kumagundane. UMutagenesis 2008; 23: 261-265. Buka okungaqondakali.
  30. IMilioli, EM, Cologni, P., Santos, CC, Marcos, TD, Yunes, VM, Fernandes, MS, Schoenfelder, T., neCosta-Campos, L. Umphumela wokuphathwa okunamandla kokukhishwa kwe-hydroalcohol kwe-Ilex paraguariensis St Hilaire ( Aquifoliaceae) ezinhlotsheni zezilwane zesifo sikaParkinson. I-Phytother.I-2007; 21: 771-776. Buka okungaqondakali.
  31. UMartin, I., Lopez-Vilchez, M. A., Mur, A., Garcia-Algar, O., Rossi, S., Marchei, E., noPichini, S. Neonatal syndrome yokuhoxiswa ngemuva kokuphuza komama omama okungapheli. I-Ther Drug Monit. 2007; 29: 127-129. Buka okungaqondakali.
  32. UMosimann, A. L., Wilhelm-Filho, D., no da Silva, E. L. Ukukhishwa okunamanzi kwe-Ilex paraguariensis kunciphisa ukuqhubeka kwe-atherosclerosis konogwaja abondliwe yi-cholesterol. Ama-Biofactors 2006; 26: 59-70. Buka okungaqondakali.
  33. UGorzalczany, S., Filip, R., Alonso, M. R., Mino, J., Ferraro, G. E., no-Acevedo, C. Umphumela weCholeretic kanye nokuqhutshwa kwamathumbu emathumbu 'womlingani' (Ilex paraguariensis) kanye nabashintshi bawo noma iziphingi. J Ethnopharmacol. 2001; 75 (2-3): 291-294. Buka okungaqondakali.
  34. UFonseca, C. A., Otto, S. S., Paumgartten, F. J., noLeitao, A. C. Imisebenzi engeyingozi, ye-mutagenic, ne-clastogenic kaMate-Chimarrao (Ilex paraguariensis). J.Environ.Pathol.Toxicol.Oncol. 2000; 19: 333-346. Buka okungaqondakali.
  35. UMartinet, A., Hostettmann, K., noSchutz, Y. Imiphumela ye-Thermogenic yamalungiselelo ezitshalo athengiswayo ahlose ukwelapha ukukhuluphala komuntu. I-Phytomedicine. 1999; 6: 231-238. Buka okungaqondakali.
  36. UPittler, M.H, Schmidt, K., no-Ernst, E. Imicimbi emibi yezithako zokudla ngamakhambi zokwehlisa isisindo somzimba: ukubuyekeza okuhlelekile. Obes. 2005; 6: 93-111. Buka okungaqondakali.
  37. UPittler, M.H no-Ernst, E. Izithako zokudla zokwehlisa isisindo somzimba: ukubuyekeza okuhlelekile. Am. J. Umthambo Wezempilo. 2004; 79: 529-536. Buka okungaqondakali.
  38. UDickel, M. L., Rates, S. M., noRitter, M. R. Izitshalo ezisetshenziselwa ukuxegisela isisindo ePorto Alegre, eSouth Brazil. UJ Ethnopharmacol 1-3-2007; 109: 60-71. Buka okungaqondakali.
  39. UFotherby, M. D., Ghandi, C., Haigh, R. A., Macdonald, T. A., noPotter, uJ. I-Cardiology kwabadala 1994; 2: 499-503.
  40. UJeppesen, U., Loft, S., Poulsen, H. E., noBrsen, K. Ucwaningo lokusebenzisana kwe-fluvoxamine-caffeine. I-Pharmacogenetics 1996; 6: 213-222. Buka okungaqondakali.
  41. USmits, P., Ababolekisi, J. W., noTeen, T. Caffeine kanye ne-theophylline banqanda i-adenosine eyenziwe nge-vasodilation kubantu. Umtholampilo. Pharmacol. 1990; 48: 410-418. Buka okungaqondakali.
  42. I-Gronroos, i-N.N ne-Alonso, A. Ukudla kanye nobungozi bokuqina kwe-atrial - i-epidemiologic kanye nobufakazi bemitholampilo -. Isiyingi. J 2010; 74: 2029-2038. Buka okungaqondakali.
  43. UClausen, T. Ukuguqulwa kwamahomoni nokwenziwa kwemithi kwe-plasma potassium homeostasis. I-Fundam.Clin Pharmacol 2010; 24: 595-605. Buka okungaqondakali.
  44. Reis, J. P., Loria, C. M., Steffen, L. M., Zhou, X., van, Uphondo L., Siscovick, D. S., Jacobs, D.R., Jr., noCarr, J. J. Coffee, ikhofi enamanzi, i-caffeine, nokusetshenziswa kwetiye ebudaleni nase-atherosclerosis kamuva empilweni: isifundo seCARDIA. I-Arterioscler.Thromb.Vasc.Ibhayisikili 2010; 30: 2059-2066. Buka okungaqondakali.
  45. UBracesco, N., Sanchez, A. G., Contreras, V., Menini, T., noGugliucci, A. Intuthuko yakamuva ocwaningweni lwe-Ilex paraguariensis: Minireview. J Ethnopharmacol. 6-26-2010; Buka okungaqondakali.
  46. UConen, D., Chiuve, S. E., Everett, B. M., Zhang, S. M., Buring, J. E., no-Albert, C. M. Caffeine ukusetshenziswa kanye ne-atrial fibrillation kwabesifazane. Ngingu-J J Nutriti 2010; 92: 509-514. Buka okungaqondakali.
  47. U-Ernest, D., Chia, M., noCalloallo, C. E. I-hypokalaemia ejulile ngenxa yokusebenzisa kabi i-Nurofen Plus ne-Red Bull. Ukuvuselelwa Kwe-Crit Care. 2010; 12: 109-110. Buka okungaqondakali.
  48. URigato, I., Blarasin, L., noKette, F. I-hypokalemia enzima kubagibeli abancane bebhayisikili abayi-2 ngenxa yokudla okukhulu kwe-caffeine. I-Clin J Sport Med. 2010; 20: 128-130. Buka okungaqondakali.
  49. USimmonds, M. J., Minahan, C. L., noSabapathy, S. Caffeine ithuthukisa ukuhamba ngebhayisikili okuphezulu kepha hhayi isilinganiso sokukhishwa kwamandla kwe-anaerobic. I-Eur. J Appl Physiol 2010; I-109: 287-295. Buka okungaqondakali.
  50. UZhang, W., Lopez-Garcia, E., Li, T. Y., Hu, F. B., novan Dam, R. M. Ukusetshenziswa kwekhofi kanye nobungozi bezifo zenhliziyo nemithambo yegazi nakho konke-okubangela ukufa kwamadoda ane-type 2 yesifo sikashukela. Ukunakekelwa yisifo sikashukela 2009; 32: 1043-1045. Buka okungaqondakali.
  51. Lopez-Garcia, E., Rodriguez-Artalejo, F., Rexrode, K. M., Logroscino, G., Hu, F. B., ne van Dam, R. M. Ukusetshenziswa kwekhofi nobungozi bokushaywa unhlangothi kwabesifazane. Ukusakazwa 3-3-2009; 119: 1116-1123. Buka okungaqondakali.
  52. USmits, P., Temme, L., noTeen, T. Ukusebenzisana kwenhliziyo phakathi kwe-caffeine ne-nicotine ebantwini. I-Clin Pharmacol Ther 1993; 54: 194-204. Buka okungaqondakali.
  53. ROTH, J. L. Ukuhlolwa kwemitholampilo kokuhlaziywa kwesisu se-caffeine ezigulini ze-duodenal ulcer. I-Gastroenterology 1951; 19: 199-215. Buka okungaqondakali.
  54. UJoeres R, uRichter E. Mexiletine nokuqedwa kwe-caffeine. N Engl J Med. 1987; 317: 117. Buka okungaqondakali.
  55. UZelenitsky SA, uNorman A, uNix DE. Imiphumela ye-fluconazole kuma-pharmacokinetics we-caffeine ezifundweni ezincane nezindala. J Ukuthelela i-Dis Pharmacother 1995; 1: 1-11.
  56. UMatila MJ, uVainio P, uNurminen ML, et al. IMidazolam 12 mg iphikiswe ngokulinganisela yi-250 mg caffeine kumuntu. I-Int J Clin Pharmacol Ther 2000; 38: 581-7. Buka okungaqondakali.
  57. UMatila ME, uMatila MJ, uNuotto E. Caffeine ngokulingene uphikisana nemiphumela ye-triazolam ne-zopiclone ekusebenzeni kwengqondo kwezifundo ezinempilo. I-Pharmacol Toxicol 1992; 70: 286-9. Buka okungaqondakali.
  58. UMatila MJ, uNuotto E. Caffeine nemiphumela ye-theophylline yokulwa nemiphumela ye-diazepam kumuntu. IMed Biol. 1983; 61: 337-43. Buka okungaqondakali.
  59. UMatila MJ, uPalva E, uSavolainen K. I-Caffeine iphikisana nemiphumela ye-diazepam kumuntu. IMed Biol 1982; 60: 121-3. Buka okungaqondakali.
  60. Ifayela SE, iBond AJ, uLister RG. Ukusebenzisana phakathi kwemiphumela ye-caffeine ne-lorazepam ekuhlolweni kokusebenza nokuzikala. UJ Clin Psychopharmacol 1982; 2: 102-6. Buka okungaqondakali.
  61. UBroughton LJ, uRogers HJ. Ukwehliswa kwesitatimende se-caffeine ngenxa ye-cimetidine. UBr J Clin Pharmacol 1981; 12: 155-9. Buka okungaqondakali.
  62. U-Azcona O, uBarbanoi MJ, uTorrent J, uJane F. Ukuhlolwa kwemiphumela emaphakathi yokusebenzisana kotshwala ne-caffeine. UBr J Clin Pharmacol 1995; 40: 393-400. Buka okungaqondakali.
  63. UNorager, C. B., Jensen, M. B., Weimann, A., noMadsen, M. R. Imiphumela ye-Metabolic yokungenisa i-caffeine nomsebenzi womzimba kwizakhamizi ezineminyaka engama-75 ubudala. Isifundo esilawulwa ngokungahleliwe, esingaboni kabili, esilawulwa yi-placebo. I-Clin Endocrinol (Oxf) 2006; 65: 223-228. Buka okungaqondakali.
  64. IMay, D. C., Camisa, C., Cheney, P., Pacula, C. M., Nawoot, S., noGerber, N. Methoxsalen yisithiyo esinamandla semetabolism ye-caffeine ebantwini. Umtholampilo. Pharmacol. 1987; 42: 621-626. Buka okungaqondakali.
  65. UMohiuddin, M., Azam, A. T., Amran, M. S., noHossain, M. A. Ngemiphumela emihle ye-gliclazide ne-metformin ekugxileni kwe-plasma ye-caffeine kumagundane anempilo. UPak. J Biol Sci 5-1-2009; 12: 734-737. Buka okungaqondakali.
  66. UGasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, WA, Kleinrok, Z., noCzuczwar, uSJ Felbamate ukhombisa ukuthambekela okuphansi kokusebenzisana ne-methylxanthines kanye ne-Ca2 + modulators yesiteshi ekulweni nokuquleka kokuhlola kumagundane. . I-Eur. J Pharmacol 7-10-1998; 352 (2-3): 207-214. Buka okungaqondakali.
  67. UVaz, J., Kulkarni, C., David, J., noJoseph, T. Umthelela we-caffeine kuphrofayli ye-pharmacokinetic ye-sodium valproate ne-carbamazepine kumavolontiya avamile abantu. Indian J.Exp.Ibhayisikili. 1998; 36: 112-114. Buka okungaqondakali.
  68. UChroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., noCzuczwar, S. J. Caffeine kanye ne-anticonvulsant potency yezidakamizwa ze-antiepileptic: idatha yokuhlola neyomtholampilo. IPharmacol. 2011; 63: 12-18. Buka okungaqondakali.
  69. ILuszczki, J. J., Zuchora, M., Sawicka, K. M., Kozinska, J., noCzuczwar, S. J. Ukuvezwa kahle kwe-caffeine kunciphisa isenzo se-anticonvulsant se-ethosuximide, kepha hhayi i-clonazepam, i-phenobarbital ne-valproate ekulweni nokuhlaselwa okubangelwa yi-pentetrazole kumagundane. I-Pharmacol Rep. 2006; 58: 652-659. Buka okungaqondakali.
  70. UJankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., noCzuczwar, S. J. [I-caffeine nemithi yokulwa nesifo sokuwa: idatha yokuhlola neyomtholampilo]. I-Przegl.Lek. 2007; 64: 965-967. Buka okungaqondakali.
  71. UGasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., noCzuczwar, S. J. Umsebenzi we-Anticonvulsant we-phenobarbital ne-valproate yokulwa ne-electroshock enkulu kumagundane ngesikhathi sokwelapha okungapheli nge-caffeine ne-caffeine yokuyeka. Isifo sokuwa 1996; 37: 262-268. Buka okungaqondakali.
  72. UKot, M. noDaniel, W. A. ​​Umphumela we-diethyldithiocarbamate (DDC) kanye ne-ticlopidine emsebenzini we-CYP1A2 kanye ne-caffeine metabolism: isifundo se-in vitro sokuqhathanisa ne-CDNA yomuntu esivezwe yi-CYP1A2 kanye nama-microsomes wesibindi. I-Pharmacol Rep. 2009; 61: 1216-1220. Buka okungaqondakali.
  73. UFuhr, U., Strobl, G., Manaut, F., Anders, EM, Sorgel, F., Lopez-de-Brinas, E., Chu, DT, Pernet, AG, Mahr, G., Sanz, F. , futhi. Ama-Quinolone antibacterial agents: ubudlelwane phakathi kwesakhiwo kanye ne-in vitro inhibition ye-cytochrome yomuntu i-P450 isoform CYP1A2. UMol. Pharmacol. 1993; 43: 191-199. Buka okungaqondakali.
  74. UStille, W., Harder, S., Mieke, S., Beer, C., Shah, P. M., Frech, K., noStaib, A. H. Ukwehla kokuqedwa kwe-caffeine kumuntu ngesikhathi sokubusa ngokubambisana kwama-4-quinolones. J. Antimicrob. Umama. 1987; 20: 729-734. Buka okungaqondakali.
  75. UStaib, A.H, Stille, W., Dietlein, G., Shah, P. M., Harder, S., Mieke, S., noBhiya, C. Ukusebenzisana phakathi kwama-quinolones ne-caffeine. Izidakamizwa 1987; 34 Suppl 1: 170-174. Buka okungaqondakali.
  76. Shet, M. S., McPhaul, M., Fisher, C. W., Stallings, N. R., no-Estabrook, R. W. Metabolism wesidakamizwa se-antiandrogenic (Flutamide) yi-CYP1A2 yabantu. Izidakamizwa zeMetab Yezidakamizwa. 1997; 25: 1298-1303. Buka okungaqondakali.
  77. IKynast-Gales SA, iMassey LK. Umphumela we-caffeine ekukhishweni kwe-circadian ye-urinary calcium ne-magnesium. J Am Coll Umsoco. 1994; 13: 467-72. Buka okungaqondakali.
  78. U-Ochiai R, uJokura H, uSuzuki A, et al. Ukukhishwa kukabhontshisi okuluhlaza okuluhlaza kuthuthukisa ukungasebenzi kahle komuntu. IHypertens Res 2004; 27: 731-7. Buka okungaqondakali.
  79. IConforti AS, uGallo ME, uSaraví FD. Ukusetshenziswa kwe-Yerba Mate (Ilex paraguariensis) kuhlotshaniswa nobuningi bamathambo amaminerali kwabesifazane be-postmenopausal. Ithambo 2012; 50: 9-13. Buka okungaqondakali.
  80. URobinson LE, uSavani S, uBattram DS, et al. Ukungeniswa kwe-caffeine ngaphambi kokuhlolwa kokubekezelelana ngomlomo ngomlomo kuphazamisa ukuphathwa kweglucose egazini emadodeni ane-type 2 yesifo sikashukela. UJ Nutriti 2004; 134: 2528-33. Buka okungaqondakali.
  81. ILake CR, iRosenberg DB, iGallant S, et al. I-Phenylpropanolamine inyusa amazinga e-plasma caffeine. I-Clin Pharmacol Ther 1990; 47: 675-85. Buka okungaqondakali.
  82. I-Forrest WH Jr, iBellville JW, uBrown BW Jr. Ukusebenzisana kwe-caffeine ne-pentobarbital njenge-hypnotic yasebusuku. I-Anesthesiology 1972; 36: 37-41. Buka okungaqondakali.
  83. URaaska K, uRaitasuo V, uLaitila J, uNeuvonen PJ. Imiphumela yekhofi equkethe i-caffeine uma iqhathaniswa ne-decaffeinated on concentrations ye-serum clozapine ezigulini ezibhedlela. I-Basic Clin Pharmacol Toxicol 2004; 94: 13-8. Buka okungaqondakali.
  84. UWatson JM, uSherwin RS, uDeary IJ, et al. Ukuhlukaniswa kwempendulo engathandwayo yomzimba, yehomoni nokuqonda kwi-hypoglycaemia ngokusetshenziswa okuqhubekayo kwe-caffeine. I-Clin Sci (Lond) 2003; 104: 447-54. Buka okungaqondakali.
  85. I-Winkelmayer WC, iStampfer MJ, iWillett WC, iCurhan GC. Ukudla okuvamile kwe-caffeine kanye nengozi yomfutho wegazi ophezulu kwabesifazane. I-JAMA 2005; 294: 2330-5. Buka okungaqondakali.
  86. UJuliano LM, uGriffiths RR. Ukubuyekezwa okubucayi kokuhoxiswa kwe-caffeine: ukuqinisekiswa kwezimpawu nezimpawu, izehlakalo, ubunzima, nezici ezihambisanayo. I-Psychopharmacology (Berl) 2004; 176: 1-29. Buka okungaqondakali.
  87. ULeson CL, McGuigan MA, uBryson SM. Ukudlula ngokweqile kwe-caffeine kowesilisa osemusha. UJ Toxicol Clin Toxicol 1988; 26: 407-15. Buka okungaqondakali.
  88. UBenowitz NL, u-Osterloh J, uGoldschlager N, et al. Ukukhishwa okukhulu kwe-catecholamine kusuka kubuthi be-caffeine. I-JAMA 1982; 248: 1097-8. Buka okungaqondakali.
  89. U-Acheson KJ, uGremaud G, Meirim I, et al. Imiphumela ye-Metabolic ye-caffeine ebantwini: i-lipid oxidation noma ibhayisekili eliyize? Ngingu-J J Nutriti 2004; 79: 40-6. Buka okungaqondakali.
  90. IHallerle CA, uBenowitz NL, uJacob P 3rd. Imiphumela ye-Hemodynamic ye-ephedra-free weight-supplements supplements kubantu. U-Am J Med 2005; 118: 998-1003 .. Buka okungaqondakali.
  91. ISantos IS, iMatijasevich A, iValle NC. Ukuphuza umlingani ngesikhathi sokukhulelwa kanye nengozi yokuzalwa ngaphambi kwesikhathi nokuncane kokuzalwa kweminyaka yobudala. J Okunomsoco 2005; 135: 1120-3. Buka okungaqondakali.
  92. UPetrie HJ, Chown SE, uBelfie LM, et al. Ukungeniswa kwe-caffeine kwandisa impendulo ye-insulin ekuhlolweni kokubekezela ngomlomo noshukela emadodeni akhuluphele ngaphambi nangemva kokulahleka kwesisindo. Ngingu-J J Nutriti 2004; 80: 22-8. Buka okungaqondakali.
  93. ILane JD, iBarkauskas CE, iSurwit RS, iFeinglos MN. I-caffeine iphazamisa i-glucose metabolism kuhlobo 2 lwesifo sikashukela. Ukunakekelwa yisifo sikashukela 2004; 27: 2047-8. Buka okungaqondakali.
  94. USaldana MD, uZetzl C, uMohamed RS, uBrunner G. Ukukhishwa kwe-methylxanthines kusuka embewini ye-guarana, amaqabunga womlingani, nobhontshisi wecocoa besebenzisa i-carbon dioxide ne-ethanol. J Agric Ukudla Chem 2002; 50: 4820-6. Buka okungaqondakali.
  95. U-Andersen T, Fogh J. Ukwehla kwesisindo nokubambezeleka kokuqedwa kwesisu kulandela ukulungiswa kwamakhambi aseNingizimu Melika ezigulini ezikhuluphele. Ukudla kukaJ Hum Nutr 2001; 14: 243-50. Buka okungaqondakali.
  96. U-Esmelindro AA, uGirardi Jdos S, uMossi A, et al. Ithonya lokuhlukahluka kwe-agronomic ekwakhiweni kwamaqabunga etiyi womlingani (i-Ilex paraguariensis) akhiwe atholakala kokukhishwa kwe-CO2 ku-30 ​​degrees C no-175 bar. J Agric Ukudla Chem 2004; 52: 1990-5. Buka okungaqondakali.
  97. Sewram V, De Stefani E, Brennan P, Boffetta P. Mate ukusetshenziswa kanye nengozi yomdlavuza we-squamous cell esophageal e-uruguay. I-Cancer Epidemiol Biomarkers Prev 2003; 12: 508-13. Buka okungaqondakali.
  98. UGoldenberg D, uGolz A, uJoachims HZ. Umlingani wesiphuzo: ingozi yokuthola umdlavuza ekhanda nasentanyeni. INhloko yeNhloko 2003; 25: 595-601. Buka okungaqondakali.
  99. ICannon ME, iCooke CT, iMcCarthy JS. I-cardiac arrhythmia eyenziwe nge-caffeine: ingozi engaziwa yemikhiqizo yokudla yezempilo. IMed J Aust 2001; 174: 520-1. Buka okungaqondakali.
  100. I-Durrant KL. Imithombo eyaziwayo nefihliwe ye-caffeine kwizidakamizwa, ekudleni nasemikhiqizweni yemvelo. UJ Am Pharm Assoc 2002; 42: 625-37. Buka okungaqondakali.
  101. UDews PB, O'Brien CP, uBergman J. Caffeine: imiphumela yokuziphatha yokuhoxa nezinkinga ezihlobene. Ukudla Chem Toxicol 2002; 40: 1257-61. Buka okungaqondakali.
  102. UHolmgren P, uNorden-Pettersson L, u-Ahlner J. Caffeine oshonile - imibiko yamacala amane. I-Forensic Sci Int 2004; 139: 71-3. Buka okungaqondakali.
  103. UChou T. Vuka uzwe iphunga lekhofi. I-caffeine, ikhofi, kanye nemiphumela yezokwelapha. ENtshonalanga J Med 1992; 157: 544-53. Buka okungaqondakali.
  104. UHowell LL, uCoffin VL, uSpealman RD. Imiphumela yokuziphatha nokuziphatha kwama-xanthine kuma-primates angewona awabantu. I-Psychopharmacology (Berl) 1997; 129: 1-14. Buka okungaqondakali.
  105. Isikhungo Sezokwelapha. I-Caffeine Yokusimamiswa Kokusebenza Komsebenzi Wengqondo: Amafomula Wokusebenza Kwezempi. Washington, DC: National Academy Press, 2001. Itholakala ku: http://books.nap.edu/books/0309082587/html/index.html.
  106. UZheng XM, uWilliam RC. Amazinga e-serum caffeine ngemuva kokungavunyelwe kwamahora angama-24: imiphumela yomtholampilo ekucabangeni kwe-dipyridamole Tl myocardial perfusion. UJ Nucl Med Technol 2002; 30: 123-7. Buka okungaqondakali.
  107. U-Aqel RA, uZoghbi GJ, uTrimm JR, et al. Imiphumela ye-caffeine efakwa ngemithambo yegazi ku-intracoronary-ephethwe i-adenosine-indone coronary hemodynamics ezigulini ezinesifo semithambo yegazi. NginguJ J Cardiol 2004; 93: 343-6. Buka okungaqondakali.
  108. Underwood i-DA. Imiphi imishanguzo okufanele ibanjwe ngaphambi kokuhlolwa kwe-pharmacologic noma kokuvivinya umzimba? ICleve Clin J Med 2002; 69: 449-50. Buka okungaqondakali.
  109. USmith A. Imiphumela ye-caffeine ekuziphatheni komuntu. Ukudla Chem Toxicol 2002; 40: 1243-55. Buka okungaqondakali.
  110. UStanek EJ, uMelko GP, uCharland SL. Ukuphazamiseka kweXanthine ne-dipyridamole-thallium-201 imaging myocardial. Ikhemisi 1995; 29: 425-7. Buka okungaqondakali.
  111. UCarrillo JA, uBenitez J.Ukuxhumana okuphawulekayo kwemithi phakathi kokudla okune-caffeine nemithi. Umtholampilo Pharmacokinet 2000; 39: 127-53. Buka okungaqondakali.
  112. I-Wahllander A, i-Paumgartner G. Umphumela we-ketoconazole ne-terbinafine kuma-pharmacokinetics we-caffeine kumavolontiya anempilo. I-Eur J Clin Pharmacol 1989; 37: 279-83. Buka okungaqondakali.
  113. USanderink GJ, uBournique B, uStevens J, et al. Ukubandakanywa kwama-isoenzymes we-CYP1A womuntu ekuxhumaneni kwe-metabolism kanye nezidakamizwa ze-riluzole in vitro. I-Pharmacol Exp Ther 1997; 282: 1465-72. Buka okungaqondakali.
  114. UBrown NJ, uRyder D, uGatsha RA. Ukusebenzisana kwe-pharmacodynamic phakathi kwe-caffeine ne-phenylpropanolamine. I-Clin Pharmacol Ther 1991; 50: 363-71. Buka okungaqondakali.
  115. U-Abernethy DR, Todd EL. Ukukhubazeka kokuvunyelwa kwe-caffeine ngokusetshenziswa okungapheli kwezindlela zokuvimbela inzalo zomlomo ezinomthamo ophansi. I-Eur J Clin Pharmacol 1985; 28: 425-8. Buka okungaqondakali.
  116. UMay DC, uJarboe CH, uVanBakel AB, uWilliam WM. Imiphumela ye-cimetidine esimweni se-caffeine kubantu ababhemayo nabangabhemi. I-Clin Pharmacol Ther 1982; 31: 656-61. Buka okungaqondakali.
  117. UNawrot P, Jordan S, Eastwood J, et al. Imiphumela ye-caffeine empilweni yomuntu. I-Addit Contam yokudla 2003; 20: 1-30. Buka okungaqondakali.
  118. UMassey LK, uWhiting SJ. I-caffeine, i-calcium yomchamo, i-calcium metabolism kanye nethambo. UJ Nutriti 1993; 123: 1611-4. Buka okungaqondakali.
  119. I-Infante S, iBaeza ML, iCalvo M, et al. I-Anaphylaxis ngenxa ye-caffeine. Ukungezwani komzimba 2003; 58: 681-2. Buka okungaqondakali.
  120. UNix D, uZelenitsky S, uSymonds W, et al. Umphumela we-fluconazole kuma-pharmacokinetics we-caffeine ezifundweni ezincane nezindala. I-Clin Pharmacol Ther 1992; 51: 183.
  121. UKockler DR, uMcCarthy MW, uLawson CL. Umsebenzi wokubamba nokungaphenduli ngemuva kokungeniswa kwe-hydroxycut. I-Pharmacotherapy 2001; 21: 647-51 .. Buka okungaqondakali.
  122. IGrandjean AC, iReimers KJ, iBannick KE, iHaven MC. Umphumela weziphuzo ezine-caffeine, ezingenayo i-caffeine, i-caloric kanye ne-non-caloric ku-hydration. J Am Coll Nutriti 2000; 19: 591-600 .. Buka okungaqondakali.
  123. UDreher HM. Umphumela wokwehliswa kwe-caffeine kwikhwalithi yokulala nenhlalakahle kubantu abane-HIV. J Psychosom Res 2003; 54: 191-8 .. Buka okungaqondakali.
  124. IMassey LK. Ingabe i-caffeine iyingozi ekulahlekelweni kwethambo kubantu asebekhulile? Ngingu-J J Clin Nutr 2001; 74: 569-70. Buka okungaqondakali.
  125. UMcGowan JD, Altman RE, Kanto WP Jr.Izimpawu zokuhoxa kweNonatal ngemuva kokungeniswa okungapheli komama nge-caffeine. ISouth Med J 1988; 81: 1092-4 .. Buka okungaqondakali.
  126. IBara AI, iBarley EA. I-caffeine yesifuba somoya. ICochrane Database Syst Rev 2001; 4: CD001112 .. Buka okungaqondakali.
  127. UHorner NK, uLampe JW. Izindlela ezingaba khona zokwelashwa kokudla kwezimo zesifuba se-fibrocystic zibonisa ubufakazi obanele bokusebenza. J Am Diet Assoc 2000; 100: 1368-80. Buka okungaqondakali.
  128. UBell DG, uJacobs I, u-Ellerington K. Umphumela we-caffeine ne-ephedrine ukungenisa ekusebenzeni kokuzivocavoca kwe-anaerobic. IMed Sci Sports Exerc 2001; 33: 1399-403. Buka okungaqondakali.
  129. I-Avisar R, i-Avisar E, i-Weinberger D. Umphumela wokusetshenziswa kwekhofi ekucindezelekeni kwe-intraocular. I-Ann Pharmacother 2002; 36: 992-5 .. Buka okungaqondakali.
  130. UFerrini RL, uBarrett-Connor E.Ukudla kwe-Caffeine namazinga we-sexo angapheli kwabesifazane be-postmenopausal. Isifundo seRancho Bernardo. Ngingu-J Epidemiol 1996: 144: 642-4. Buka okungaqondakali.
  131. U-Ardlie NG, uGlew G, uSchultz BG, uSchwartz CJ. Ukuvimbela nokubuyisa ukuhlanganiswa kweplatelet ngama-methyl xanthines. UTromb Diath Haemorrh 1967; 18: 670-3. Buka okungaqondakali.
  132. U-Ali M, u-Afzal M. I-inhibitor enamandla ye-thrombin evuselele ukwakheka kweplatelet thromboxane kusuka etiyeni elingasetshenziswanga. AmaProstaglandins Leukot Med 1987; 27: 9-13. Buka okungaqondakali.
  133. IHallerle CA, uBenowitz NL. Imicimbi emibi yenhliziyo nemithambo yegazi ehambisana nezithako zokudla eziqukethe i-ephedra alkaloids. N Engl J Med 2000; 343: 1833-8. Buka okungaqondakali.
  134. USinclair CJ, uGiiger JD. Ukusetshenziswa kwe-caffeine kwezemidlalo. Ukubuyekezwa kwemithi. J Ezemidlalo Med Fitness 2000; 40: 71-9. Buka okungaqondakali.
  135. I-American Academy Yezingane. Ukudluliswa kwezidakamizwa namanye amakhemikhali obisini lomuntu. Izifo zezingane 2001; 108: 776-89. Buka okungaqondakali.
  136. ULloyd T, uJohnson-Rollings N, u-Eggli DF, et al. Isimo samathambo phakathi kwabesifazane be-postmenopausal abanokudla okuhlukile kwe-caffeine: uphenyo olude. UJ Am Coll Nutriti 2000; 19: 256-61. Buka okungaqondakali.
  137. UWatson JM, uJenkins EJ, uHamilton P, et al. Ithonya le-caffeine kumvamisa nasekuboneni kwe-hypoglycemia ezigulini eziphila mahhala ezinesifo sikashukela sohlobo 1. Ukunakekelwa yisifo sikashukela 2000; 23: 455-9. Buka okungaqondakali.
  138. UFetrow CW, u-Avila JR. IProfessional’s Handbook of Complementary & Alternative Medicines. 1st ed. ISpringhouse, PA: ISpringhouse Corp., 1999.
  139. UMcGee J, uPatrick RS, uWood CB, uBlumgart LH. Icala lesifo se-veno-occlusive sesibindi eBrithani esihlobene nokusetshenziswa kwetiye yamakhambi. UJ Clin Pathol 1976; 29: 788-94. Buka okungaqondakali.
  140. UHagg S, Spigset O, Mjorndal T, Dahlqvist R. Umphumela we-caffeine kuma-pharmacokinetics e-clozapine kumavolontiya anempilo. UBr J Clin Pharmacol 2000; 49: 59-63. Buka okungaqondakali.
  141. UWilliam MH, uGatsha JD. Dala ukwengeza nokusebenza kokuzivocavoca: isibuyekezo. UJ Am Coll Nutriti 1998; 17: 216-34. Buka okungaqondakali.
  142. I-FDA. Umthetho ophakanyisiwe: izithako zokudla eziqukethe i-ephedrine alkaloids. Itholakala ku: www.verity.fda.gov (Ifinyelelwe ngomhla ka-25 Januwari 2000).
  143. UDews PB, uC Curtis GL, uHanford KJ, u-O'Brien CP. Ukuvama kokuhoxa kwe-caffeine kunhlolovo esekwe kubantu nasekuhlolweni okulawulwayo, okuyimpumputhe. UJ Clin Pharmacol 1999; 39: 1221-32. Buka okungaqondakali.
  144. UNurminen ML, Niittynen L, Korpela R, Vapaatalo H. Ikhofi, i-caffeine nomfutho wegazi: ukubuyekeza okubucayi. I-Eur J Clin Nutr 1999; 53: 831-9. Buka okungaqondakali.
  145. UDiPiro JT, uTalbert RL, Yee GC, et al; ama-eds. I-Pharmacotherapy: Indlela ye-pathophysiologic. Umhla wesi-4. IStamford, CT: I-Appleton neLange, 1999.
  146. UPollock BG, uWylie M, uStack JA, et al. Ukuvinjelwa kwe-caffeine metabolism nge-estrogen therapy esikhundleni sabesifazane be-postmenopausal. UJ Clin Pharmacol 1999; 39: 936-40. Buka okungaqondakali.
  147. I-Wemple RD, iWundlu DR, uMcKeever KH. I-caffeine vs iziphuzo zemidlalo ezingenayo i-caffeine: imiphumela ekukhiqizeni umchamo ngesikhathi sokuphumula nangesikhathi sokuzivocavoca isikhathi eside. I-Int J Sports Med 1997; 18: 40-6. Buka okungaqondakali.
  148. IStookey JD. Imiphumela yokuchama yotshwala ne-caffeine kanye nokuhlanjululwa kwamanzi okuphelele. I-Eur J Epidemiol 1999; 15: 181-8. Buka okungaqondakali.
  149. UFernandes O, Sabharwal M, uSmiley T, et al.Ukusetshenziswa okulingene kuya okusindayo kwe-caffeine ngesikhathi sokukhulelwa nobudlelwano nokukhipha isisu okuzenzekelayo nokukhula okungavamile kombungu: ukuhlaziywa kwe-meta. I-Reprod Toxicol 1998; 12: 435-44. Buka okungaqondakali.
  150. UKlebanoff MA, uLevine RJ, uDerSimonian R, et al. I-maternal serum paraxanthine, i-caffeine metabolite, kanye nengozi yokukhipha isisu ngokuzenzekelayo. N Engl J Med 1999; 341: 1639-44. Buka okungaqondakali.
  151. Uhlelo Lukazwelonke Lwe-Toxicology (NTP). Ikhafeyini. Isikhungo Sokuhlolwa Kwezingozi Zokukhiqizwa Komuntu (CERHR). Itholakala ku: http://cerhr.niehs.nih.gov/common/caffeine.html.
  152. URapuri PB, uGallagher JC, uKinyamu HK, uRyschon KL. Ukudla kwe-caffeine kukhuphula izinga lokulahleka kwamathambo kwabesifazane asebekhulile futhi kuhlangana ne-vitamin D receptor genotypes. Ngingu-J J Clin Nutr 2001; 74: 694-700. Buka okungaqondakali.
  153. I-Chiu KM. Ukusebenza kwe-calcium supplements ku-bone mass kwabesifazane be-postmenopausal. UJ Gerontol A Biol Sci Med Sci 1999; 54: M275-80. Buka okungaqondakali.
  154. UVandeberghe K, Gillis N, Van Leemputte M, et al. I-caffeine iphikisana nesenzo se-ergogenic sokulayisha kwemisipha ye-muscle. UJ Appl Physiol 1996; 80: 452-7. Buka okungaqondakali.
  155. Ukuchazwa Kwezilingo Zokuxilonga. Amazwibela weLaboratory Medicine. Okwesihlanu ed; IBoston, MA: Little Brown, 1992.
  156. UDe Stefani E, uFierro L, uCorrea P, et al. Ukuphuza umlingani kanye nengozi yomdlavuza wamaphaphu kwabesilisa: isifundo esilawula icala esivela e-Uruguay. I-Cancer Epidemiol Biomarkers Prev 1996; 5: 515-9. Buka okungaqondakali.
  157. UDe Stefani E, uCorrea P, uFierro L, et al. Ugwayi omnyama, umlingani nomdlavuza wesisu. Ucwaningo lokulawulwa kwamacala oluvela e-Uruguay. Umdlavuza 1991; 67: 536-40. Buka okungaqondakali.
  158. UDe Stefani E, uFierro L, uMendilaharsu M, et al. Ukudla inyama, ukuphuza 'umlingani' nomdlavuza wamangqamuzana e-Uruguay: isifundo sokulawulwa kwamacala. Br J Umdlavuza 1998; 78: 1239-43. Buka okungaqondakali.
  159. UPintos J, uFranco EL, u-Oliveira BV, et al. I-Mate, ikhofi, nokusetshenziswa kwetiye kanye nobungozi bomdlavuza womgudu ongaphezulu we-aerodigestive eningizimu yeBrazil. I-Epidemiology 1994; 5: 583-90. Buka okungaqondakali.
  160. UHodgson JM, uPuddey IB, uBurke V, et al. Imiphumela yengcindezi yegazi yokuphuza itiye eliluhlaza nokumnyama. UJ Hypertens 1999; 17: 457-63. Buka okungaqondakali.
  161. Wakabayashi K, Kono S, Shinchi K, et al. Ukusetshenziswa kwekhofi ejwayelekile nokucindezelwa kwegazi: Ucwaningo lwezikhulu zokuzivikela eJapan. I-Eur J Epidemiol 1998; 14: 669-73. Buka okungaqondakali.
  162. Okwe-Dieter, Cishe Ukulahlekelwa Kokugcina. IWashington Post. Kutholakala ku: http://www.washingtonpost.com/archive/politics/2000/03/19/for-dieter-nearly-the-ultimate-loss/c0f07474-489d-4f44-bc17-1f1367c956ae/ (Kufinyelelwe ngo-19 Mashi 2000 ).
  163. UVahedi K, uDomingo V, u-Amarenco P, uBousser MG. Ukushaywa yischemic kumuntu wezemidlalo odle okukhishwe uMaHuang futhi wakha i-monohydrate yokwakha umzimba. UJ Neurol Neurosurg Psychiatr 2000; 68: 112-3. Buka okungaqondakali.
  164. UJoeres R, uKlinker H, uHeusler H, et al. Ithonya le-mexiletine ekususweni kwe-caffeine. I-Pharmacol Ther 1987; 33: 163-9. Buka okungaqondakali.
  165. UHsu CK, uLeo P, uShastry D, et al. Ubuthi be-Anticholinergic obuhambisana netiye yamakhambi. I-Arch Intern Med 1995; 155: 2245-8. Buka okungaqondakali.
  166. UHealy DP, uPolk RE, uKanawati L, et al. Ukusebenzisana phakathi komlomo we-ciprofloxacin ne-caffeine kumavolontiya ajwayelekile. Ama-Antimicrob Agents Chemother 1989; 33: 474-8. Buka okungaqondakali.
  167. UCarbo M, uSegura J, uDe la Torre R, et al. Umphumela wama-quinolone esimweni se-caffeine. I-Clin Pharmacol Ther 1989; 45: 234-40. Buka okungaqondakali.
  168. I-Harder S, i-Fuhr U, i-Staib AH, i-Wolff T. Ciprofloxacin-caffeine: ukuxhumana kwezidakamizwa okusungulwe kusetshenziswa uphenyo lwe-vivo kanye ne-in vitro. NginguJ Med 1989; 87: 89S-91S. Buka okungaqondakali.
  169. UMorris JC, Beeley L, Ballantine N. Ukusebenzisana kwe-ethinyloestradiol ne-ascorbic acid kumuntu [incwadi]. UBr Med J (Clin Res Ed) 1981; 283: 503. Buka okungaqondakali.
  170. UGotz V, uRomankiewicz JA, uMoss J, uMurray HW. I-Prophylaxis yokulwa nohudo oluhambisana ne-ampicillin ngokulungiselela i-lactobacillus. NginguJ J Hosp Pharm 1979; 36: 754-7. Buka okungaqondakali.
  171. UShearer MJ, uBach A, uKohlmeier M. Chemistry, imithombo yokudla okunempilo, ukusatshalaliswa kwezicubu kanye ne-metabolism ka-vitamin K ngokubhekisele ngokukhethekile empilweni yethambo. UJ Nutriti 1996; 126: 1181S-6S. Buka okungaqondakali.
  172. UMcEvoy GK, umhleli. Imininingwane Yezidakamizwa ze-AHFS. I-Bethesda, MD: I-American Society of Health-System Pharmacists, ngo-1998.
  173. Ukubuyekezwa Kwemikhiqizo Yemvelo ngamaqiniso nokuqhathanisa. ISt. Louis, MO: IWolters Kluwer Co., 1999.
  174. UBlumenthal M, u-ed. I-Complete German Commission E Monographs: Umhlahlandlela Wezokwelapha Emithini Yemithi. I-Trans. S. Klein. IBoston, MA: Umkhandlu Wezamabhodlela waseMelika, ngo-1998.
Kugcine ukubuyekezwa - 06/04/2019

Izincwadi Zethu

I-laparoscopic gastric banding - ukukhipha
Umuthi

I-laparoscopic gastric banding - ukukhipha

Uhlinzwe ngamabhande e i wini uku iza ekunciphi eni i i indo. Le ndat hana ikut hela ukuthi ungazinakekela kanjani ngemuva kwenqubo.Une-laparo copic ga tric banding urgery uku iza ekunciphi eni i i in...
Izinguquko enganeni esanda kuzalwa lapho izalwa
Umuthi

Izinguquko enganeni esanda kuzalwa lapho izalwa

Izinguquko ezinganeni ezi anda kuzalwa lapho zizalwa zi ho izinguquko ezitholwa ngumzimba wo ana ukuze zivumelane nempilo engaphandle kwe ibeletho. AMAPHALA, INHLIZIYO, NEZIT HIZI ZEGAZII-placenta kam...